Efficacy and Safety of Dalbavancin As Suppressive Therapy

This study is looking into a medicine called Dalbavancin, often shortened to DAL. It's a special type of antibiotic used to treat serious infections caused by certain bacteria, like those that can affect your skin, bones, joints, and other parts of your body. Doctors sometimes use DAL as a 'suppressive therapy,' which means taking it for a longer period to keep tough infections under control, especially if other treatments haven't worked well.

Dalbavancin is designed to be very effective against these bacteria. It works by stopping them from building their protective cell walls, which ultimately kills them. One of its key features is that it stays in your body for a long time, sometimes for several days, meaning it might not need to be given as often as some other antibiotics. The study is particularly interested in how well DAL has worked for patients who received it as a long-term treatment.

The main goal of this research is to understand how effective and safe Dalbavancin has been when used in this way. The researchers will be looking at information from patients who were given DAL for infections between July 2019 and December 2024. They want to learn more about the types of patients who received it, their general health, and how well the treatment helped manage their infections. This information will help doctors better understand when and how to use Dalbavancin for people with challenging infections.